Search

Your search keyword '"Magro, F"' showing total 843 results
Start Over Author "Magro, F"
843 results on '"Magro, F"'

1. Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus

Author

Abreu, M, Ahuja, V, Allez, M, Ananthakrishnan, A, Bemelman, W, Bernstein, C, Braun, J, Chowers, Y, Colombel, J-F, Danese, S, D'Haens, G, D'Hoore, A, Dignass, A, Dotan, I, Dubinsky, M, Ekbom, A, Fleshner, P, Gasche, C, Gassull, MA, Gearry, R, Ghosh, S, Gibson, P, Griffiths, A, Halfvarson, J, Hanauer, S, Harpaz, N, Hart, A, Hibi, T, Kamm, M, Kaplan, G, Kaser, A, Korelitz, B, Kotze, P, Koutroubakis, I, Kruis, W, Lakatos, P, Lewis, J, Lindsay, J, Loftus, E, Louis, E, Lukas, M, Magro, F, Mahadevan, U, Mantzaris, G, Mary, J-Y, McGovern, D, Moum, B, Munkholm, P, Neurath, M, Ng, S, O'Morain, C, Oresland, T, Panaccione, R, Panes, J, Panis, Y, Pemberton, J, Peyrin-Biroulet, L, Prantera, C, Rachmilewitz, D, Ran, Z, Reinisch, W, Remzi, F, Rhodes, J, Riddell, R, Rogler, G, Rubin, D, Sachar, D, Sandborn, W, Sands, B, Sartor, B, Schoelmerich, J, Schreiber, S, Siegel, C, Siegmund, B, Silverberg, M, Söderholm, J, Sood, A, Spinelli, A, Stange, E, Steinwurz, F, Targan, S, Travis, S, Turner, D, Tysk, C, Vatn, M, Vermeire, S, Watanabe, M, Yamamoto, T, Yamamoto-Furusho, J, Ananthakrishnan, Ashwin N, Kaplan, Gilaad G, Bernstein, Charles N, Burke, Kristin E, Lochhead, Paul J, Sasson, Alexa N, Agrawal, Manasi, Tiong, Jimmy Ho Tuan, Steinberg, Joshua, Kruis, Wolfgang, Steinwurz, Flavio, Ahuja, Vineet, Ng, Siew C, Rubin, David T, Colombel, Jean-Frederic, and Gearry, Richard

Published
2022
Full Text
View/download PDF

4. P658 Safety and efficacy of MH002, an optimized live biotherapeutic product, for the treatment of mild to moderate ulcerative colitis: a first-in-disease, double-blind, randomized clinical trial

Author

Vermeire, S, primary, Dewint, P, additional, Vansteelant, M, additional, Peterka, M, additional, Štěpek, D, additional, Kierkuś, J, additional, Wiernicka, A, additional, Napora, P, additional, Wolański, Ł, additional, Kopoń, A, additional, Magro, F, additional, Pinheiro, I, additional, Possemiers, S, additional, Haazen, L, additional, and Bolca, S, additional

Published
2024
Full Text
View/download PDF

7. P430 The influence of persistent organ damage on IFX pharmacokinetic modeling and disease progression assessment: findings from a prospective real-world study in inflammatory bowel disease patients

Author

Magro, F, primary, Fernandes, S, additional, Patita, M, additional, Arroja, B, additional, Lago, P, additional, Rosa, I, additional, Tavares de Sousa, H, additional, Ministro, P, additional, Mocanu, I, additional, Vieira, A, additional, Castela, J, additional, Moleiro, J, additional, Roseira, J, additional, Cancela, E, additional, Sousa, P, additional, Portela, F, additional, Correia, L, additional, Moreira, P, additional, Afonso, J, additional, Dias, S, additional, Danese, S, additional, Peyrin-Biroulet, L, additional, Vucicevic, K, additional, and Santiago, M, additional

Published
2024
Full Text
View/download PDF

12. DOP01 Definitions of histological abnormalities in inflammatory bowel disease: an ECCO position paper

Author

Rosini, F, primary, Feakins, R M, additional, Borralho Nunes, P, additional, Driessen, A, additional, Gordon, I O, additional, Zidar, N, additional, Baldin, P, additional, Christensen, B, additional, Danese, S, additional, Herlihy, N, additional, Iacucci, M, additional, Loughrey, M B, additional, Magro, F, additional, Mookhoek, A, additional, and Svrcek, M, additional

Published
2024
Full Text
View/download PDF

13. OP10 Efficacy and safety of upadacitinib in patients with moderately to severely active Crohn’s Disease: results from the U-ENDURE long-term extension

Author

D'Haens, G, primary, Louis, E, additional, Loftus Jr., E V, additional, Regueiro, M, additional, Jairath, V, additional, Magro, F, additional, Nakase, H, additional, Dubcenco, E, additional, Lacerda, A P, additional, Feng, T, additional, Duncan, B, additional, Wang, T, additional, Ford, S, additional, Anyanwu, S I, additional, and Blumenstein, I, additional

Published
2024
Full Text
View/download PDF

16. P666 Accuracy of information given by ChatGPT for patients with Inflammatory Bowel Disease in relation to ECCO guidelines

Author

Farrugia, Y, primary, Sciberras, M, additional, Gordon, H, additional, Furfaro, F, additional, Allocca, M, additional, Torres, J, additional, Arebi, N, additional, Fiorino, G, additional, Iacucci, M, additional, Verstockt, B, additional, Magro, F, additional, Katsanos, K, additional, Fenech, V A, additional, Chetcuti Zammit, S, additional, and Ellul, P, additional

Published
2024
Full Text
View/download PDF

21. Assessing comprehensive remission for Ulcerative Colitis in clinical practice : International consensus recommendations

Author

Schreiber, S. W., Danese, S., Dignass, A., Domènech, E., Fantini, M., Ferrante, M., Halfvarson, Jonas, Hart, A., Magro, F., Lees, C., Leone, S., Pierik, M., Field, P., Schofield, H., Peyrin-Biroulet, L., Schreiber, S. W., Danese, S., Dignass, A., Domènech, E., Fantini, M., Ferrante, M., Halfvarson, Jonas, Hart, A., Magro, F., Lees, C., Leone, S., Pierik, M., Field, P., Schofield, H., and Peyrin-Biroulet, L.

Published
2023
Full Text
View/download PDF

23. P777 Deployment of an artificial intelligence tool for precision medicine in ulcerative colitis: Preliminary data from 8 globally distributed clinical sites

Author

Peyrin-Biroulet, L, primary, Rubin, D, additional, Weber, C, additional, Adsul, S, additional, Freire, M, additional, Biedermann, L, additional, Koelzer, V, additional, Bressler, B, additional, Xiong, W, additional, Niess, J, additional, Matthias Matter, M M, additional, Kopylov, U, additional, Barshack, I, additional, Mayer, C, additional, Magro, F, additional, Carneiro, F, additional, Maharshak, N, additional, Greenberg, A, additional, Hart, S, additional, Dehmeshki, J, additional, and Kubassova, O, additional

Published
2023
Full Text
View/download PDF

24. P151 Assessing comprehensive remission for Ulcerative Colitis in clinical practice: International consensus recommendations

Author

Schreiber, S W, primary, Danese, S, additional, Dignass, A, additional, Domènech, E, additional, Fantini, M, additional, Ferrante, M, additional, Halfvarson, J, additional, Hart, A, additional, Magro, F, additional, Lees, C, additional, Leone, S, additional, Pierik, M, additional, Field, P, additional, Schofield, H, additional, and Peyrin-Biroulet, L, additional

Published
2023
Full Text
View/download PDF

25. P602 Achievement of stringent histologic and composite endpoints in subjects with moderately to severely active ulcerative colitis treated with etrasimod: a post hoc analysis of the phase 3 ELEVATE UC 52 and ELEVATE UC 12 trials

Author

Magro, F, primary, Peyrin-Biroulet, L, additional, Sands, B E, additional, Danese, S, additional, Jairath, V, additional, Goetsch, M, additional, Bhattacharjee, A, additional, Wu, J, additional, Ferreira Branquinho, D, additional, Modesto, I, additional, and Feagan, B G, additional

Published
2023
Full Text
View/download PDF

26. P734 A single measurement of fecal calprotectin, particularly if combined with hemoglobin and C-reactive protein levels, predicts Crohn’s disease prognosis - a prospective study

Author

Magro, F, primary, Estevinho, M M, additional, Catalano, G, additional, Patita, M, additional, Arroja, B, additional, Lago, P, additional, Rosa, I, additional, Tavares-de-Sousa, H, additional, Ministro, P, additional, Roseira, J, additional, Cancela, E, additional, Sousa, P, additional, Portela, F, additional, Correia, L, additional, Moreira, P, additional, Santiago, M, additional, Dias, S, additional, Afonso, J, additional, Danese, S, additional, Peyrin-Biroulet, L, additional, and Dias, C C, additional

Published
2023
Full Text
View/download PDF

28. P379 Effect of upadacitinib on inflammatory markers and clinical outcomes in patients with Crohn’s disease in the phase 3, U-EXCEL, U-EXCEED, and U-ENDURE studies

Author

Vermeire, S, primary, Danese, S, additional, Cohen, B L, additional, Magro, F, additional, Chen, Y, additional, Ha, C, additional, Dubcenco, E, additional, Lacerda, A P, additional, Marced, E, additional, Oomen, J, additional, Garrison, A, additional, and Peyrin-Biroulet, L, additional

Published
2023
Full Text
View/download PDF

29. Transmural Remission Improves Clinical Outcomes Up to 5 years in Crohn's Disease

Author

Raimundo Fernandes, S, Serrazina, J, Ayala Botto, I, Leal, T, Guimarães, A, Lemos Garcia, J, Rosa, I, Prata, R, Carvalho, D, Neves, J, Campelo, P, Ventura, S, Silva, A, Coelho, M, Sequeira, C, Oliveira, AP, Portela, F, Ministro, P, Tavares de Sousa, H, Ramos, J, Claro, I, Gonçalves, R, Araújo Correia, L, Tato Marinho, R, Cortez Pinto, H, and Magro, F

Subjects
Magnetic Resonance Imaging / methods, Crohn Disease* / diagnostic imaging, Remission Induction, Humans, HSAC GAS, Colonoscopy, Crohn Disease* / drug therapy, Retrospective Studies
Abstract

Introduction: Evidence supporting transmural remission (TR) as a long-term treatment target in Crohn's disease (CD) is still unavailable. Less stringent but more reachable targets such as isolated endoscopic (IER) or radiologic remission (IRR) may also be acceptable options in the long-term. Methods: Multicenter retrospective study including 404 CD patients evaluated by magnetic resonance enterography and colonoscopy. Five-year rates of hospitalization, surgery, use of steroids, and treatment escalation were compared between patients with TR, IER, IRR, and no remission (NR). Results: 20.8% of CD patients presented TR, 23.3% IER, 13.6% IRR and 42.3% NR. TR was associated with lower risk of hospitalization (odds-ratio [OR] 0.244 [0.111-0.538], p < 0.001), surgery (OR 0.132 [0.030-0.585], p = 0.008), steroid use (OR 0.283 [0.159-0.505], p < 0.001), and treatment escalation (OR 0.088 [0.044-0.176], p < 0.001) compared to no NR. IRR resulted in lower risk of hospitalization (OR 0.333 [0.143-0.777], p = 0.011) and treatment escalation (OR 0.260 [0.125-0.540], p < 0.001), while IER reduced the risk of steroid use (OR 0.442 [0.262-0.745], p = 0.002) and treatment escalation (OR 0.490 [0.259-0.925], p = 0.028) compared to NR. Conclusions: TR improved clinical outcomes over 5 years of follow-up in CD patients. Distinct but significant benefits were seen with IER and IRR. This suggests that both endoscopic and radiologic remission should be part of the treatment targets of CD. info:eu-repo/semantics/publishedVersion

Published
2023

30. Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: Results of the 2011 ECCO-EpiCom inception cohort

Author

Vegh, Z., Burisch, J., Pedersen, N., Kaimakliotis, I., Duricova, D., Bortlik, M., Avnstrøm, S., Vinding, K. Kofod, Olsen, J., Nielsen, K.R., Katsanos, K.H., Tsianos, E.V., Lakatos, L., Schwartz, D., Odes, S., Lupinacci, G., De Padova, A., Jonaitis, L., Kupcinskas, L., Turcan, S., Tighineanu, O., Mihu, I., Barros, L.F., Magro, F., Lazar, D., Goldis, A., Fernandez, A., Hernandez, V., Niewiadomski, O., Bell, S., Langholz, E., Munkholm, P., and Lakatos, P.L.

Published
2014
Full Text
View/download PDF

32. Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with Inflammatory Bowel Disease — An ECCO-EpiCom study

Author

Burisch, J., Weimers, P., Pedersen, N., Cukovic-Cavka, S., Vucelic, B., Kaimakliotis, I., Duricova, D., Bortlik, M., Shonová, O., Vind, I., Avnstrøm, S., Thorsgaard, N., Krabbe, S., Andersen, V., Dahlerup, J.F., Kjeldsen, J., Salupere, R., Olsen, J., Nielsen, K.R., Manninen, P., Collin, P., Katsanos, K.H., Tsianos, E.V., Ladefoged, K., Lakatos, L., Ragnarsson, G., Björnsson, E., Bailey, Y., O'Morain, C., Schwartz, D., Odes, S., Valpiani, D., Boni, M.C., Jonaitis, L., Kupcinskas, L., Turcan, S., Barros, L., Magro, F., Lazar, D., Goldis, A., Nikulina, I., Belousova, E., Fernandez, A., Sanroman, L., Almer, S., Zhulina, Y., Halfvarson, J., Arebi, N., Diggory, T., Sebastian, S., Lakatos, P.L., Langholz, E., and Munkholm, P.

Published
2014
Full Text
View/download PDF

33. Health care and patients' education in a European inflammatory bowel disease inception cohort: An ECCO-EpiCom study

Author

Burisch, J., Vegh, Z., Pedersen, N., Čuković-Čavka, S., Turk, N., Kaimakliotis, I., Duricova, D., Bortlik, M., Shonová, O., Thorsgaard, N., Krabbe, S., Andersen, V., Dahlerup, J.F., Kjeldsen, J., Salupere, R., Olsen, J., Nielsen, K.R., Manninen, P., Collin, P., Katsanos, K.H., Tsianos, E.V., Ladefoged, K., Ragnarsson, G., Björnsson, E., Bailey, Y., O'Morain, C., Schwartz, D., Odes, S., Politi, P., Santini, A., Kiudelis, G., Kupcinskas, L., Turcan, S., Magro, F., Barros, L., Lazar, D., Goldis, A., Nikulina, I., Belousova, E., Sanromán, L., Martinez-Ares, D., Almer, S., Zhulina, Y., Halfvarson, J., Arebi, N., Houston, Y., Sebastian, S., Langholz, E., Lakatos, P.L., and Munkholm, P.

Published
2014
Full Text
View/download PDF

34. Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe — An ECCO-EpiCom study

Author

Burisch, J., Pedersen, N., Cukovic-Cavka, S., Turk, N., Kaimakliotis, I., Duricova, D., Bortlik, M., Shonová, O., Vind, I., Avnstrøm, S., Thorsgaard, N., Krabbe, S., Andersen, V., Dahlerup, J.F., Kjeldsen, J., Salupere, R., Olsen, J., Nielsen, K.R., Manninen, P., Collin, P., Katsanos, K.H., Tsianos, E.V., Ladefoged, K., Lakatos, L., Ragnarsson, G., Björnsson, E., Bailey, Y., O'Morain, C., Schwartz, D., Odes, S., Giannotta, M., Girardin, G., Kiudelis, G., Kupcinskas, L., Turcan, S., Barros, L., Magro, F., Lazar, D., Goldis, A., Nikulina, I., Belousova, E., Martinez-Ares, D., Hernandez, V., Almer, S., Zhulina, Y., Halfvarson, J., Arebi, N., Tsai, H.H., Sebastian, S., Lakatos, P.L., Langholz, E., and Munkholm, P.

Published
2014
Full Text
View/download PDF

35. Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

Author

Rahier, J.F., Magro, F., Abreu, C., Armuzzi, A., Ben-Horin, S., Chowers, Y., Cottone, M., de Ridder, L., Doherty, G., Ehehalt, R., Esteve, M., Katsanos, K., Lees, C.W., MacMahon, E., Moreels, T., Reinisch, W., Tilg, H., Tremblay, L., Veereman-Wauters, G., Viget, N., Yazdanpanah, Y., Eliakim, R., and Colombel, J.F.

Published
2014
Full Text
View/download PDF

37. DOP019 Immunomodulators reduce the risk of surgery and hospitalisation in Crohn’s disease in a prospective European population-based inception cohort: the Epi-IBD cohort

Author

Burisch, J, Andersen, V, Čuković-Čavka, S, Lakatos, P L, DʼInca, R, Magro, F, Arebi, N, Kievit, L, Kaimakliotis, I, Valpiani, D, Katsanos, K H, Vegh, Z, Dahlerup, J F, Fumery, M, Pedersen, N, Halfvarson, J, Belousova, E, Nielsen, K R, Turcan, S, Ellul, P, Kupcinskas, L, Oksanen, P, Duricova, D, Giannotta, M, Goldis, A, Hernandez, V, Salupere, R, Odes, S, Langholz, E, and Munkholm, P

Published
2018
Full Text
View/download PDF

38. Contributors

Author

Abruzzo, A., primary, Alahmadi, A., additional, Arthur, J.C., additional, Bakker, G.J., additional, Bercik, P., additional, Bertelsen, R.J., additional, Britton, R.A., additional, Burton, J.P., additional, Carr, J.S., additional, Carroll, I.M., additional, Chanyi, R.M., additional, Chibbar, R., additional, Cifone, M.G., additional, Cinque, B., additional, Ciorba, M.A., additional, Combs, M., additional, Comelli, E.M., additional, Darby, T.M., additional, Dieleman, L.A., additional, Ding, N.S., additional, Donelli, G., additional, Doron, S., additional, Ellermann, M., additional, Eloit, M., additional, Fine, S., additional, Floch, M.H., additional, Floch, N., additional, Fodor, A.A., additional, Freitas, M., additional, Gorbach, S., additional, Green, P.H.R., additional, Guandalini, S., additional, Guslandi, M., additional, Hart, A., additional, Hickman, R.A., additional, Hod, K., additional, Holmes, E., additional, Jenkins, D.J.A., additional, Jensen, E.T., additional, Jones, R.M., additional, Kelly, C.R., additional, Kendall, C.W.C., additional, Khan, A., additional, Krishnareddy, S., additional, Kroeker, K.I., additional, La Torre, C., additional, Lecuit, M., additional, Lombardi, F., additional, Lu, C., additional, Madsen, K., additional, Magro, F., additional, Mastromarino, P., additional, McFarland, L.V., additional, Mitmesser, S., additional, Neish, A.S., additional, Neto, A.G., additional, Nieuwdorp, M., additional, Noronha, J.C., additional, Nossa, C., additional, Nowak-Wegrzyn, A., additional, Palumbo, P., additional, Park, H., additional, Pei, Z., additional, Philip, V., additional, Pitchumoni, C.S., additional, Punzalan, C., additional, Qamar, A., additional, Quigley, E.M.M., additional, Ringel, Y., additional, Ringel-Kulka, T., additional, Sansotta, N., additional, Sarafian, M.H., additional, Sarkar, A., additional, Schultz, M., additional, Sievenpiper, J.L., additional, Szajewska, H., additional, Treisman, G.J., additional, van den Rest, M.E., additional, Vitali, B., additional, Vuotto, C., additional, Walker, W.A., additional, and Wong, J.M.W., additional

Published
2017
Full Text
View/download PDF

40. Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus

Author

Ananthakrishnan, Ashwin N, primary, Kaplan, Gilaad G, additional, Bernstein, Charles N, additional, Burke, Kristin E, additional, Lochhead, Paul J, additional, Sasson, Alexa N, additional, Agrawal, Manasi, additional, Tiong, Jimmy Ho Tuan, additional, Steinberg, Joshua, additional, Kruis, Wolfgang, additional, Steinwurz, Flavio, additional, Ahuja, Vineet, additional, Ng, Siew C, additional, Rubin, David T, additional, Colombel, Jean-Frederic, additional, Gearry, Richard, additional, Abreu, M, additional, Ahuja, V, additional, Allez, M, additional, Ananthakrishnan, A, additional, Bemelman, W, additional, Bernstein, C, additional, Braun, J, additional, Chowers, Y, additional, Colombel, J-F, additional, Danese, S, additional, D'Haens, G, additional, D'Hoore, A, additional, Dignass, A, additional, Dotan, I, additional, Dubinsky, M, additional, Ekbom, A, additional, Fleshner, P, additional, Gasche, C, additional, Gassull, MA, additional, Gearry, R, additional, Ghosh, S, additional, Gibson, P, additional, Griffiths, A, additional, Halfvarson, J, additional, Hanauer, S, additional, Harpaz, N, additional, Hart, A, additional, Hibi, T, additional, Kamm, M, additional, Kaplan, G, additional, Kaser, A, additional, Korelitz, B, additional, Kotze, P, additional, Koutroubakis, I, additional, Kruis, W, additional, Lakatos, P, additional, Lewis, J, additional, Lindsay, J, additional, Loftus, E, additional, Louis, E, additional, Lukas, M, additional, Magro, F, additional, Mahadevan, U, additional, Mantzaris, G, additional, Mary, J-Y, additional, McGovern, D, additional, Moum, B, additional, Munkholm, P, additional, Neurath, M, additional, Ng, S, additional, O'Morain, C, additional, Oresland, T, additional, Panaccione, R, additional, Panes, J, additional, Panis, Y, additional, Pemberton, J, additional, Peyrin-Biroulet, L, additional, Prantera, C, additional, Rachmilewitz, D, additional, Ran, Z, additional, Reinisch, W, additional, Remzi, F, additional, Rhodes, J, additional, Riddell, R, additional, Rogler, G, additional, Rubin, D, additional, Sachar, D, additional, Sandborn, W, additional, Sands, B, additional, Sartor, B, additional, Schoelmerich, J, additional, Schreiber, S, additional, Siegel, C, additional, Siegmund, B, additional, Silverberg, M, additional, Söderholm, J, additional, Sood, A, additional, Spinelli, A, additional, Stange, E, additional, Steinwurz, F, additional, Targan, S, additional, Travis, S, additional, Turner, D, additional, Tysk, C, additional, Vatn, M, additional, Vermeire, S, additional, Watanabe, M, additional, Yamamoto, T, additional, and Yamamoto-Furusho, J, additional

Published
2022
Full Text
View/download PDF

42. Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines

Author

Panes, J., Bouhnik, Y., Reinisch, W., Stoker, J., Taylor, S.A., Baumgart, D.C., Danese, S., Halligan, S., Marincek, B., Matos, C., Peyrin-Biroulet, L., Rimola, J., Rogler, G., van Assche, G., Ardizzone, S., Ba-Ssalamah, A., Bali, M.A., Bellini, D., Biancone, L., Castiglione, F., Ehehalt, R., Grassi, R., Kucharzik, T., Maccioni, F., Maconi, G., Magro, F., Martín-Comín, J., Morana, G., Pendsé, D., Sebastian, S., Signore, A., Tolan, D., Tielbeek, J.A., Weishaupt, D., Wiarda, B., and Laghi, A.

Published
2013
Full Text
View/download PDF

43. Cromo

Author

Michele Cortelazzo, Mauro Sambi, Fabio Magro, Luigi Matt, Enrico Mattioda, Mariano Venanzi, Marino Brustolon, Elio Giamello, Giuseppe Silvestri, Matteo M. Pedroni, Carlo Enrico Roggia, Emanuele Zinato, Domenico Scarpa, Mario Barenghi, Alessandra Zangrandi, Attilio Motta, Laura Neri, Niccolò Scaffai, Arnaldo Soldani, Piero Benzoni, Anna Baldini, Martina Mengoni, Elena Ghibaudi, Magro, F, Sambi, M, Barenghi, M, Michele Cortelazzo, Mauro Sambi, Fabio Magro, Luigi Matt, Enrico Mattioda, Mariano Venanzi, Marino Brustolon, Elio Giamello, Giuseppe Silvestri, Matteo M. Pedroni, Carlo Enrico Roggia, Emanuele Zinato, Domenico Scarpa, Mario Barenghi, Alessandra Zangrandi, Attilio Motta, Laura Neri, Niccolò Scaffai, Arnaldo Soldani, Piero Benzoni, Anna Baldini, Martina Mengoni, Elena Ghibaudi, Magro, F, Sambi, M, and Barenghi, M

Abstract

"Cromo" ha una posizione abbastanza straordinaria sia nella compagine del volume in cui è inserito ("Il sistema periodico") sia nell'insieme dell'opera di Primo Levi. Qui, eccezionalmente, l'autore parla della genesi di "Se questo è un uomo"; racconta un momento cruciale della sua esistenza, il ritorno alla vita civile dopo Auschwitz; fornisce un quadro quanto mai ricco degli aspetti pratici e sociali, oltre che cognitivi, della chimica; squaderna una serie di interessi per i fenomeni linguistici e culturali. "Cromo" è dunque un ritratto in nuce di Levi chimico, intellettuale e scrittore.

Published
2022

44. P695 The risk of proximal disease extension in patients with limited ulcerative colitis in a prospective European population-based inception cohort – the ECCO-EpiCom cohort

Author

Burisch, J., Halfvarson, J., Kupcinskas, L., Hernandez, V., Kaimakliotis, I., Valpiani, D., Pedersen, N., Duricova, D., Kievit, L., Dahlerup, J.F., Fumery, M., Salupere, R., Arebi, N., Nielsen, K.R., Giannotta, M., Oksanen, P., Katsanos, K.H., Vegh, Z., Ellul, P., Schwartz, D., Čuković-Čavka, S., DʼIncà, R., Turcan, S., Magro, F., Goldis, A., Langholz, E., Lakatos, P.L., and Munkholm, P.

Published
2017
Full Text
View/download PDF

45. P727 Change in Crohnʼs disease behavior in a prospective European population-based inception cohort – the ECCO-EpiCom cohort

Author

Burisch, J., Halfvarson, J., Kupcinskas, L., Hernandez, V., Kaimakliotis, I., Valpiani, D., Pedersen, N., Duricova, D., Kievit, L., Dahlerup, J.F., Fumery, M., Salupere, R., Arebi, N., Nielsen, K.R., Giannotta, M., Oksanen, P., Katsanos, K.H., Vegh, Z., Ellul, P., Schwartz, D., Čuković-Čavka, S., DʼIncà, R., Turcan, S., Magro, F., Goldis, A., Langholz, E., Lakatos, P.L., and Munkholm, P.

Published
2017
Full Text
View/download PDF

46. P694 Disease course during the first five years following diagnosis in a prospective European population-based inception cohort – the ECCO-EpiCom cohort

Author

Burisch, J., Halfvarson, J., Kupcinskas, L., Hernandez, V., Kaimakliotis, I., Valpiani, D., Pedersen, N., Duricova, D., Kievit, L., Dahlerup, J.F., Fumery, M., Salupere, R., Arebi, N., Nielsen, K.R., Giannotta, M., Oksanen, P., Katsanos, K.H., Vegh, Z., Ellul, P., Schwartz, D., Čuković-Čavka, S., DʼIncà, R., Turcan, S., Magro, F., Goldis, A., Langholz, E., Lakatos, P.L., and Munkholm, P.

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results